Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads

Recruiting N/A Interventional Study
SARS- CoV-2 Cardiovascular Diseases Chronic Kidney Diseases Diabetes Mellitus, Type 2 Chronic Disease Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
500 (estimated)
Sponsor
University of South Carolina · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconomically disadvantaged, older, and Black/African American from rural regions are burdened with greater…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: COVID-19 survivor inclusion criteria * African American * Male and female * Living in a Medically Underserved Area and/or a designated rural area of South Carolina * ≥ 18 years and above * A history of a COVID-19-associated hospitalization, ER or Urgent Care visit since March 1…
Contacts

Study PI

8037779160

magwoodg@sc.edu

CONTACT

Program Coordinator

(803) 576-7787

CONTACT